AlphaYouMP
Schedule 13G filing
MOLL PETER disclosed a 5.2% stake in Werewolf Therapeutics, Inc. (HOWL)
MOLL PETER reported owning 5.2% of Werewolf Therapeutics, Inc. (HOWL) (2,537,138 shares) in a Schedule 13G filed Sep 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 21, 2026
- Source
- Schedule 13G
More HOWL insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.